← Back to Search

Surveys for Portable Ultrasound

N/A
Waitlist Available
Led By Michael V Knopp, MD, PhD
Research Sponsored by Ohio State University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up through study completion, an average of 1-3 years
Awards & highlights
No Placebo-Only Group

Summary

This trial is to test if a new ultrasound system is feasible to use in the clinical setting. There is no immediate impact or benefit for patients participating in the study, but the study could improve the use of ultrasound in the future.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~through study completion, an average of 1-3 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and through study completion, an average of 1-3 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Ultrasound Image Quality

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups
Experimental Treatment
Group I: Student and staff populationExperimental Treatment1 Intervention
To understand the impact of ultraportable ultrasound, survey tools will be used to understand the workflow and clinical care applications and integration of these devices. All staff and student members will be appropriately consented; however, we anticipate that this portion of the study will be minimal risk.
Group II: Patient populationExperimental Treatment2 Interventions
When a patient receives an ultrasound examination as part of standard of care or within another clinical research trial, such an examination may serve for an intra-individual comparator examination between conventional and new, ultra-portable ultrasound imaging. Patients will be identified in the clinical setting when appropriate and will be appropriately approached for consent for a combination of ultrasound with the physical exam, for medical student education, IV access, and novel application. Patients will be enrolled and accounted for in the appropriate sub-population.
Group III: Healthy volunteer populationExperimental Treatment2 Interventions
The volunteer population will allow us to practice the use of this equipment and understand the limitations and applicability. The results will be the images acquired as well as surveys from the volunteers and those performing the scans, who will be enrolled in the staff population of this study.

Find a Location

Who is running the clinical trial?

Ohio State UniversityLead Sponsor
866 Previous Clinical Trials
655,157 Total Patients Enrolled
University of CincinnatiLead Sponsor
436 Previous Clinical Trials
635,362 Total Patients Enrolled
Ohio Third FrontierOTHER
5 Previous Clinical Trials
691 Total Patients Enrolled
~0 spots leftby Dec 2024